Anaplastic Thyroid Carcinoma: A Therapeutic Dilemma
Open Access
- 1 January 2005
- journal article
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 46 (6) , 759-764
Abstract
Chang HS, et al. Yonsei Med J. 2005 Dec;46(6):759-764. http://dx.doi.org/10.3349/ymj.2005.46.6.759Keywords
This publication has 29 references indexed in Scilit:
- Gene Therapy of Anaplastic Thyroid Carcinoma with a Single-Chain Interleukin-12 Fusion ProteinHuman Gene Therapy, 2003
- Retinoic acid for redifferentiation of thyroid cancer--does it hold its promise?European Journal of Endocrinology, 2003
- Anaplastic thyroid cancerCurrent Opinion in Oncology, 2003
- BMP-7-Induced Cell Cycle Arrest of Anaplastic Thyroid Carcinoma Cells via p21CIP1 and p27KIP1Biochemical and Biophysical Research Communications, 2001
- Prognostic Factors and Therapeutic Strategy for Anaplastic Carcinoma of the ThyroidWorld Journal of Surgery, 2001
- Histone Deacetylase Inhibitors Promote Apoptosis and Differential Cell Cycle Arrest in Anaplastic Thyroid Cancer CellsThyroid®, 2001
- Anaplastic thyroid carcinomaCurrent Treatment Options in Oncology, 2000
- Prognostic factors for thyroid carcinomaCancer, 1997
- Anaplastic carcinoma of the thyroid: A 24‐year experienceHead & Neck, 1995
- Multimodality treatment in anaplastic giant cell thyroid carcinomaCancer, 1987